VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Quinacrine
Preclinical
Small molecule
C
Cleveland BioLabs
1
Indications
4
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Prion Disease
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Prion Disease
Preclinical
Completed
Clinical
Trials by Indication
[1]
Prion Disease
1 trial
PRION-1: Quinacrine for Human Prion Disease
Completed
·
M
Medical Research Council
·
N/A
·
NCT00104663
·
160 enrolled
Prostate Cancer
1 trial
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
Completed
·
C
Cleveland BioLabs
·
Phase 2
·
NCT00417274
·
31 enrolled
NAC
1 trial
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Completed
·
U
University of California, San Francisco
·
Phase 2
·
NCT00183092
·
69 enrolled
Renal Cell Carcinoma
1 trial
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
Withdrawn
·
C
Cleveland BioLabs
·
Phase 2
·
NCT00574483
Sources
References
[1]
ClinicalTrials.gov
—
4 trial records for Quinacrine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Quinacrine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Quinacrine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Cleveland BioLabs company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
C
Cleveland BioLabs
Related News